LKFT Stock News & Catalysts – Lakefront Biotherapeutics

FEATURED

Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting

Gamgertamig data from ongoing Phase 1b studies suggest potential to retain remission after B cell reconstitution, maintained in the absence of background therapy for autoimmune cytopenias, consistent with an "immune

Summary

Nov 4, 2026, 9:01 AM ·Globe Newswire

RECENT

Lakefront Biotherapeutics Welcomes Dr. Mehdi Shahidi to its Board of Directors

Dr. Shahidi brings extensive drug development experience, regulatory success, and transformative operational expertise to the Board Mechelen, Belgium; November 2, 2026, 22.01 CET; Lakefront Biotherapeutics NV

Nov 2, 2026, 4:01 PM ·Globe Newswire

Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics

Previously announced wind-down of the legacy cell therapy activities is substantially complete Mechelen, Belgium; October 14, 2026, 22.01 CEST; Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) today

Oct 14, 2026, 4:01 PM ·Globe Newswire

Lakefront Receives Transparency Notification from Bank of America

Mechelen, Belgium; October 8, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) received a transparency notification from Bank of America. Pursuant to Belgian

Oct 8, 2026, 4:01 PM ·Globe Newswire

Acquisition of Own Shares

Mechelen, Belgium; September 22, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT)

Sep 22, 2026, 4:01 PM ·Globe Newswire

Acquisition of Own Shares

Mechelen, Belgium; 08 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT)

Sep 8, 2026, 4:02 PM ·Globe Newswire

Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Mechelen, Belgium; 8 September 2026, 22.01 CET; Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) today announced that the Company will host a fireside chat at the Morgan Stanley 24th Annual Global Healthcare

Sep 8, 2026, 4:01 PM ·Globe Newswire

Lakefront Receives Transparency Notification from Bank of America

Mechelen, Belgium; August 24, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) received a transparency notification from Bank of America. Pursuant to Belgian

Aug 24, 2026, 4:01 PM ·Globe Newswire

U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus

Mechelen, Belgium; 24 August 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug

Aug 24, 2026, 4:01 PM ·Globe Newswire

Keymed Biosciences Announces 2026 H1 Results and Business Updates

CHENGDU, China, Aug. 20, 2026 /PRNewswire/ -- On August 19, 2026, Keymed Biosciences (HKEX: 02162) announced its interim results for the six months ended June 30, 2026. Guided by a clear dual-engine driven strategy, the

Aug 20, 2026, 10:09 AM ·PRNewswire

Acquisition of Own Shares

Mechelen, Belgium; 12 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT)

Aug 12, 2026, 4:01 PM ·Globe Newswire

Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update

Completed acquisition of Ouro Medicines with Gilead Sciences to advance potential first and best-in-class T-cell engager Forecast at least €1.6B of cash remaining after funding portfolio to first gamgertamig approval

Aug 10, 2026, 4:01 PM ·Globe Newswire

Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi

Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research &

Jul 13, 2026, 4:01 PM ·Globe Newswire

Lakefront Receives Transparency Notification from Madison Avenue Partners

Mechelen, Belgium; June 29, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) received a transparency notification from Madison Avenue Partners. Pursuant to Belgian

Jun 29, 2026, 4:01 PM ·Globe Newswire

Acquisition of Own Shares

Mechelen, Belgium; June 16, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT)

Jun 16, 2026, 4:01 PM ·Globe Newswire

Lakefront Biotherapeutics N.V. LKFT · News